CTLA-4 mRNA levels in the FrII and FrIII subsets were lower in SSc patients than in health controls (p<0.05); however, there was no difference in CTLA-4 mRNA levels between the SSc and healthy FrI subsets (Figure 3C). The gene discussed is CTLA4; the disease is systemic sclerosis.